Emerald Advisers Inc. PA increased its stake in shares of Mead Johnson Nutrition Co. (NYSE:MJN) by 43.2% during the second quarter, Holdings Channel reports. The fund owned 23,889 shares of the company’s stock after buying an additional 7,212 shares during the period. Emerald Advisers Inc. PA’s holdings in Mead Johnson Nutrition were worth $2,168,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Geode Capital Management LLC increased its stake in Mead Johnson Nutrition by 0.5% in the first quarter. Geode Capital Management LLC now owns 1,580,432 shares of the company’s stock valued at $134,026,000 after buying an additional 7,865 shares during the last quarter. M&T Bank Corp increased its stake in Mead Johnson Nutrition by 30.5% in the first quarter. M&T Bank Corp now owns 20,609 shares of the company’s stock valued at $1,751,000 after buying an additional 4,818 shares during the last quarter. Bessemer Group Inc. increased its stake in Mead Johnson Nutrition by 634.5% in the first quarter. Bessemer Group Inc. now owns 2,894 shares of the company’s stock valued at $246,000 after buying an additional 2,500 shares during the last quarter. Riverhead Capital Management LLC increased its stake in Mead Johnson Nutrition by 9.4% in the first quarter. Riverhead Capital Management LLC now owns 49,135 shares of the company’s stock valued at $4,175,000 after buying an additional 4,216 shares during the last quarter. Finally, Sensato Investors LLC acquired a new stake in Mead Johnson Nutrition during the first quarter valued at approximately $13,841,000. Hedge funds and other institutional investors own 96.93% of the company’s stock.
Mead Johnson Nutrition Co. (NYSE:MJN) traded up 0.35% on Monday, reaching $80.45. The company had a trading volume of 1,417,761 shares. Mead Johnson Nutrition Co. has a 1-year low of $65.53 and a 1-year high of $94.40. The stock’s 50 day moving average is $80.38 and its 200-day moving average is $84.69. The stock has a market capitalization of $14.86 billion, a P/E ratio of 30.27 and a beta of 1.26.
Mead Johnson Nutrition (NYSE:MJN) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.10. Mead Johnson Nutrition had a negative return on equity of 194.30% and a net margin of 13.28%. The company earned $941.50 million during the quarter, compared to analysts’ expectations of $967.25 million. During the same period last year, the business posted $0.76 earnings per share. The firm’s revenue was down 8.8% compared to the same quarter last year. On average, equities analysts predict that Mead Johnson Nutrition Co. will post $3.48 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, October 3rd. Stockholders of record on Monday, September 19th were issued a $0.4125 dividend. This represents a $1.65 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date of this dividend was Thursday, September 15th. Mead Johnson Nutrition’s dividend payout ratio is presently 62.03%.
MJN has been the subject of several research analyst reports. Credit Suisse Group AG reiterated a “buy” rating and issued a $96.00 price objective on shares of Mead Johnson Nutrition in a report on Thursday, June 30th. Susquehanna reiterated a “hold” rating on shares of Mead Johnson Nutrition in a report on Monday, August 8th. Goldman Sachs Group Inc. reduced their price objective on Mead Johnson Nutrition from $96.00 to $85.00 and set a “neutral” rating for the company in a report on Tuesday, September 27th. BMO Capital Markets restated an “outperform” rating and set a $96.00 price target (down from $97.00) on shares of Mead Johnson Nutrition in a research note on Saturday. Finally, Societe Generale downgraded Mead Johnson Nutrition from a “buy” rating to a “hold” rating and cut their price target for the company from $100.00 to $95.00 in a research note on Friday, July 29th. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $94.75.
In other news, SVP Graciela Monteagudo sold 45,873 shares of the stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $87.64, for a total value of $4,020,309.72. Following the transaction, the senior vice president now directly owns 13,800 shares of the company’s stock, valued at $1,209,432. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kimberly A. Casiano sold 710 shares of the stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the completion of the transaction, the director now directly owns 7,110 shares in the company, valued at $638,122.50. The disclosure for this sale can be found here. 0.50% of the stock is owned by insiders.
Mead Johnson Nutrition Company Profile
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Want to see what other hedge funds are holding MJN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mead Johnson Nutrition Co. (NYSE:MJN).
Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with MarketBeat.com's FREE daily email newsletter.